D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$301M |
| 3 |
Bausch Health
BHC
|
+$273M |
| 4 |
SPDR Gold Trust
GLD
|
+$231M |
| 5 |
Amazon
AMZN
|
+$218M |
Top Sells
| 1 |
LyondellBasell Industries
LYB
|
+$414M |
| 2 |
AGN
ALLERGAN INC
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$349M |
| 4 |
IBM
IBM
|
+$254M |
| 5 |
Microsoft
MSFT
|
+$247M |
Sector Composition
| 1 | Energy | 12.35% |
| 2 | Consumer Discretionary | 12.14% |
| 3 | Technology | 11.81% |
| 4 | Healthcare | 10.57% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODN
1276
DELISTED
MODEL N, INC.
MODN
| $2.26M | ﹤0.01% |
188,653
+36,050
| +24% | +$431K |
|
|
CARB
1277
DELISTED
Carbonite Inc
CARB
| $2.25M | ﹤0.01% |
157,542
-12,912
| -8% | -$185K |
|
|
RTEC
1278
DELISTED
Rudolph Technologies Inc
RTEC
| $2.25M | ﹤0.01% |
204,370
-12,598
| -6% | -$139K |
|
|
JWN
1279
DELISTED
Nordstrom
JWN
| $2.25M | ﹤0.01% |
+27,974
| New | +$2.25M |
|
1280
Urban Outfitters
URBN
$6.19B
| $2.25M | ﹤0.01% |
+49,184
| New | +$2.25M |
|
1281
Kennametal
KMT
$1.59B
| $2.24M | ﹤0.01% |
66,519
-164,541
| -71% | -$5.54M |
|
1282
John Wiley & Sons Class A
WLY
$2.21B
| $2.24M | ﹤0.01% |
+36,606
| New | +$2.24M |
|
|
DFRG
1283
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $2.24M | ﹤0.01% |
111,040
+90,845
| +450% | +$1.83M |
|
|
SQBK
1284
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
| $2.24M | ﹤0.01% |
83,507
+52,923
| +173% | +$1.42M |
|
|
PSB
1285
DELISTED
PS Business Parks, Inc.
PSB
| $2.23M | ﹤0.01% |
26,875
-18,844
| -41% | -$1.57M |
|
|
CNR
1286
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $2.23M | ﹤0.01% |
129,101
+66,925
| +108% | +$1.16M |
|
1287
Quantum Corp
QMCO
$102M
| $2.23M | ﹤0.01% |
8,710
-373
| -4% | -$95.5K |
|
|
ATW
1288
DELISTED
Atwood Oceanics
ATW
| $2.23M | ﹤0.01% |
79,146
-215,778
| -73% | -$6.07M |
|
|
COHR
1289
DELISTED
Coherent Inc
COHR
| $2.22M | ﹤0.01% |
34,215
+25,884
| +311% | +$1.68M |
|
|
REMY
1290
DELISTED
REMY INTL INC NEW COMMON
REMY
| $2.22M | ﹤0.01% |
+100,000
| New | +$2.22M |
|
1291
Helix Energy Solutions
HLX
$926M
| $2.21M | ﹤0.01% |
+147,681
| New | +$2.21M |
|
|
ILG
1292
DELISTED
ILG, Inc Common Stock
ILG
| $2.21M | ﹤0.01% |
84,268
-2,767
| -3% | -$72.5K |
|
|
NTT
1293
DELISTED
Nippon Telegraph & Telephone
NTT
| $2.2M | ﹤0.01% |
71,469
-184,517
| -72% | -$5.69M |
|
1294
OSI Systems
OSIS
$3.95B
| $2.2M | ﹤0.01% |
29,621
-1,609
| -5% | -$120K |
|
|
EMKR
1295
DELISTED
Emcore Corp
EMKR
| $2.2M | ﹤0.01% |
40,416
+720
| +2% | +$39.2K |
|
1296
Wipro
WIT
$29B
| $2.2M | ﹤0.01% |
879,349
+321,450
| +58% | +$803K |
|
1297
Interactive Brokers
IBKR
$28.5B
| $2.2M | ﹤0.01% |
258,132
-80,860
| -24% | -$688K |
|
|
USG
1298
DELISTED
Usg
USG
| $2.19M | ﹤0.01% |
81,937
-58,403
| -42% | -$1.56M |
|
1299
Gyre Therapeutics
GYRE
$730M
| $2.19M | ﹤0.01% |
935
| – | – |
|
1300
Xerox
XRX
$461M
| $2.19M | ﹤0.01% |
64,533
-14,869
| -19% | -$503K |
|